Secondary endpoints included changes in glucose variability using CGM, metabolic indices such as FPG, HbA1c, lipid profile, liver and renal function and urine albumin excretion, physical assessments such as BW and blood pressure, and DTSQ scores
Bottom Line With the support of health insurance companies plus high demand from consumers, GLP-1 weight loss drugs are evolving from trend to industry mainstay
Advertorial and Medical Disclaimer: This content is a sponsored advertorial produced for informational purposes in connection with a marketing arrangement
New Holland Publishers (2004), ISBN 978-1-84330-328-2 Birds of Venezuela
Because retatrutide targets all three receptors GLP-1, GIP, and GCG it is called a "triple G" or GGG tri-agonist